NeuroBo Pharmaceuticals, Inc. (NRBO) News Headlines

▮ More

Date

Headline

1/18/2023 8:23:44 AM NeuroBo Pharma Names Joseph Hooker Interim CEO & President - Quick Facts

1/18/2023 8:09:04 AM NeuroBo Pharma Appoints Joseph Hooker As Interim CEO And President

12/9/2022 6:41:02 AM Pre-market Movers: BXRX, CNCE, GROM, NRBO, BHIL…

11/8/2022 7:28:09 AM Pre-market Movers: NRBO, HIMS, OCUP, TRIP, TTWO…

9/29/2022 8:30:00 AM NeuroBo Pharmaceuticals, Inc. Compliant with All Applicable Nasdaq Listing Criteria (Press Release)

9/22/2022 11:42:30 AM NeuroBo Pharmaceuticals Stock Gains 5%

9/21/2022 7:11:49 AM Pre-market Movers: IE, SOBR, DNB, LITM, AMPX…

9/15/2022 9:05:15 AM NeuroBo Agrees With Dong-A To Develop DA-1241 & DA-1726 For NASH/Type 2 Diabetes/Obesity

9/15/2022 8:38:06 AM NeuroBo Collaborates To License And Develop Portfolio Of Dong-A's Cardio-Metabolic Therapies; Stock Surges

9/14/2022 7:31:55 AM Pre-market Movers: DWIN, SES, KSPN, NRBO, EPM…

9/13/2022 7:42:59 AM Pre-market Movers: AKRO, ETNB, CMRA, RENT, CRDF…

9/12/2022 9:42:38 AM NeuroBo Pharma Announces 1-for-30 Reverse Split Of Common Stock - Quick Facts

9/12/2022 9:20:38 AM NeuroBo Pharmaceuticals Announces 1-for-30 Reverse Split Of Common Stock

9/12/2022 9:15:00 AM NeuroBo Pharmaceuticals Announces Reverse Stock Split (Press Release)

5/6/2022 8:10:22 AM NeuroBo Pharma Appoints Matthew Bardin As SVP Operations

4/1/2022 8:06:53 AM NeuroBo Pharma FY Net Loss $15.3 Mln Or $0.66/shr Vs Net Loss Of $29.7 Mln, Or $1.83/shr Last Year

4/1/2022 8:00:00 AM NeuroBo Pharmaceuticals Reports Full Year 2021 Financial Results (Press Release)

1/25/2022 7:27:03 AM Pre-market Movers: APM, BSFC, INPX, UPC, KAVL…

1/24/2022 8:03:05 AM Pre-market Movers: BTBD, RETO, KSS, BON, PT…

11/15/2021 8:09:44 AM NeuroBo Pharmaceuticals Q3 Net Loss $3.5 Mln Or $0.16/shr Vs. Net Loss $3.1 Mln Or $0.19/shr Last Year

Neurobo Pharmaceuticals, Inc. (NRBO)